BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 29657613)

  • 1. Relationship between physician-based assessment of disease activity, quality of life, and costs of ulcerative colitis in Poland.
    Kawalec P; Stawowczyk E
    Prz Gastroenterol; 2018; 13(1):61-68. PubMed ID: 29657613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disease activity, quality of life, and indirect costs of ulcerative colitis in Poland.
    Kawalec P; Stawowczyk E; Mossakowska M; Pilc A
    Prz Gastroenterol; 2017; 12(1):60-65. PubMed ID: 28337239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health-Related Quality of Life Impairment and Indirect Cost of Crohn's Disease: A Self-Report Study in Poland.
    Holko P; Kawalec P; Mossakowska M; Pilc A
    PLoS One; 2016; 11(12):e0168586. PubMed ID: 27992531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Impact of Inflammatory Bowel Disease in Canada 2018: Indirect Costs of IBD Care.
    Kuenzig ME; Lee L; El-Matary W; Weizman AV; Benchimol EI; Kaplan GG; Nguyen GC; Bernstein CN; Bitton A; Lee K; Cooke-Lauder J; Murthy SK
    J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S34-S41. PubMed ID: 31294383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indirect Costs of Inflammatory Bowel Diseases: A Comparison of Patient-Reported Outcomes Across 12 European Countries.
    Holko P; Kawalec P; Sajak-Szczerba M; Avedano L; Mossakowska M
    Inflamm Bowel Dis; 2023 May; 29(5):752-762. PubMed ID: 35792501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disease activity, quality of life and indirect costs of psoriatic arthritis in Poland.
    Kawalec P; Malinowski KP; Pilc A
    Rheumatol Int; 2016 Sep; 36(9):1223-30. PubMed ID: 27339273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between disease severity and quality of life and assessment of health care utilization and cost for ulcerative colitis in Australia: a cross-sectional, observational study.
    Gibson PR; Vaizey C; Black CM; Nicholls R; Weston AR; Bampton P; Sparrow M; Lawrance IC; Selby WS; Andrews JM; Walsh AJ; Hetzel DJ; Macrae FA; Moore GT; Weltman MD; Leong RW; Fan T
    J Crohns Colitis; 2014 Jul; 8(7):598-606. PubMed ID: 24345767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disease activity, quality of life and indirect costs of reduced productivity at work, generated by Polish patients with ankylosing spondylitis.
    Kawalec P; Malinowski K
    Reumatologia; 2015; 53(6):301-8. PubMed ID: 27407262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Work-Related Productivity Loss and Associated Indirect Costs in Patients With Crohn's Disease or Ulcerative Colitis in the United States.
    Ding Z; Muser E; Izanec J; Lukanova R; Kershaw J; Roughley A
    Crohns Colitis 360; 2022 Jul; 4(3):otac023. PubMed ID: 36777416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Costs of ulcerative colitis from a societal perspective in a regional health care area in Spain: A database study.
    Aldeguer X; Sicras-Mainar A
    Gastroenterol Hepatol; 2016 Jan; 39(1):9-19. PubMed ID: 26211705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Productivity Loss Among Parents of Children With Inflammatory Bowel Diseases in Relation to Disease Activity and Patient's Quality of Life.
    Stawowczyk E; Kawalec P; Kowalska-Duplaga K; Mossakowska M
    J Pediatr Gastroenterol Nutr; 2020 Sep; 71(3):340-345. PubMed ID: 32459743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Health-related productivity of the Hungarian population. A cross-sectional survey].
    Péntek M; Beretzky Z; Brodszky V; Szabó JA; Kovács L; Kincses Á; Baji P; Zrubka Z; Rencz F; Gulácsi L
    Orv Hetil; 2020 Sep; 161(36):1522-1533. PubMed ID: 32886627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indirect costs associated with ulcerative colitis: a systematic literature review of real-world data.
    Constantin J; Atanasov P; Wirth D; Borsi A
    BMC Gastroenterol; 2019 Nov; 19(1):179. PubMed ID: 31706270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-Utility Analysis of Infliximab with Standard Care versus Standard Care Alone for Induction and Maintenance Treatment of Patients with Ulcerative Colitis in Poland.
    Stawowczyk E; Kawalec P; Pilc A
    Pharmacotherapy; 2016 May; 36(5):472-81. PubMed ID: 27007213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Societal costs and health related quality of life in adult atopic dermatitis.
    Beretzky Z; Koszorú K; Rencz F; Hajdu K; Borza J; Bodai K; Feifei X; Szegedi A; Sárdy M; Brodszky V
    BMC Health Serv Res; 2023 Aug; 23(1):859. PubMed ID: 37580792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Systematic Review of the Economic and Health-Related Quality of Life Impact of Advanced Therapies Used to Treat Moderate-to-Severe Ulcerative Colitis.
    Cichewicz A; Tencer T; Gupte-Singh K; Egodage S; Burnett H; Kumar J
    Adv Ther; 2023 May; 40(5):2116-2146. PubMed ID: 37000363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health-related quality of life, work productivity and costs related to patients with inflammatory bowel disease in Austria.
    Walter E; Hausberger SC; Groß E; Siebert U
    J Med Econ; 2020 Oct; 23(10):1061-1071. PubMed ID: 32713223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disease Activity and Health-related Quality of Life Relationships with Work Productivity in Patients with Ulcerative Colitis in OCTAVE Induction 1 and 2 and OCTAVE Sustain.
    Targownik L; Dubinsky MC; Steinwurz F; Bushmakin AG; Cappelleri JC; Tai E; Gardiner S; Hur P; Panés J
    J Crohns Colitis; 2023 Apr; 17(4):513-523. PubMed ID: 36271912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Work disability and productivity loss in patients with inflammatory bowel diseases in Hungary in the era of biologics.
    Mandel MD; Bálint A; Lovász BD; Gulácsi L; Strbák B; Golovics PA; Farkas K; Kürti Z; Szilágyi BK; Mohás A; Molnár T; Lakatos PL
    Eur J Health Econ; 2014 May; 15 Suppl 1():S121-8. PubMed ID: 24832845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory bowel disease-related economic costs due to presenteeism and absenteeism.
    Rankala R; Mattila K; Voutilainen M; Mustonen A
    Scand J Gastroenterol; 2021 Jun; 56(6):687-692. PubMed ID: 33826877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.